Inovio Pharmaceuticals (INO)

• Market cap: $125M
• 1 day: -0.42%
• 5 days: -8.2%
• 1 month: 0.43%
• 3 months: 65.49%
• 6 months: 21.13%
• Year to date: 29.12%
• 1 year: -55.49%
• 5 years: -98.05%
• 10 years: -97.06%
• Sector: Healthcare
• Industry: Biotechnology

About: Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.

Employees: 134